Navigation Links
FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): TGF-β Superfamily: Signaling in Development and Disease.

The 2013 "TGF-β Superfamily: Signaling in Development and Disease" is an important and unique scientific conference where the pivotal role of TGF- family members in developmental and homeostatic processes is explored through formal talks, poster sessions, and interactive and intensive scientific discussion sessions. The sessions are organized in different themes and are all held in an intimate setting with a limited number of participants.

This meeting includes outstanding researchers from around the world presenting diverse, cutting edge and forward looking research directed towards a fundamental understanding of the mechanisms of TGF-β family signaling: how these factors coordinate developmental processes, how aberrations in this signaling pathway lead to developmental abnormalities and human disease pathologies, and how this knowledge may come to be applied in the clinic.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB SRC announces conference registration open for: Mobile DNA in Mammalian Genomes
2. FASEB SRC announces conference registration open for: NAD Metabolism & Signaling
3. FASEB SRC announces conference registration open for: Histone Deacetylases, Sirtuins, and Reversible Acetylation in Signaling and Disease
4. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements
5. FASEB SRC announces conference registration open for: Signal Transduction in the Immune System
6. FASEB SRC announces conference registration open for: Biology of Cilia and Flagella
7. FASEB SRC announces conference registration open for: Arf and Rab Family G Proteins
8. FASEB SRC announces conference: Glucose transport -- Gateway for Metabolic Systems Biology
9. FASEB SRC announces conference: Mitochondrial Assembly & Dynamics in Health, Disease & Aging
10. FASEB SRC announces: Molecular Mechanisms & Physiological Consequences of Protein Aggregation
11. FASEB SRC announces conference registration open for: Neural Mechanisms in Cardiovascular Regulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... ... January 11, 2017 , ... ... Research show early promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against ... previous treatment regimens. Twenty-seven percent of these heavily pretreated patients saw clinical benefit ...
(Date:1/11/2017)... , ... January 11, 2017 , ... ... year and costing healthcare systems more than $23.7 billion, healthcare systems are ... , Among the most common sepsis-causing pathogens are bacteria and the yeast ...
(Date:1/11/2017)... ... 11, 2017 , ... Symbios Technologies, Inc., a ... Science Foundation (NSF) has awarded Symbios a Small Business Innovation Research (SBIR) ... the Symbios Tubular Plasma Reactor™ (TPR™) by scaling the system for first customer ...
(Date:1/11/2017)... 11, 2017  GenVec, Inc. (NASDAQ: ... today that its chief scientific officer, Douglas ...  "AdenoVerse™ platform for translational development of innovative gene ... the upcoming Phacilitate Cell & Gene Therapy World ... Florida.  Dr. Brough,s presentation will highlight the utility ...
Breaking Biology Technology: